A major breakthrough in cancer study is emerging with the use of nanobodies to reactivate damaged p53. This essential cancer inhibitor protein is frequently disabled in several kinds of malignancies, resulting https://pukkabookmarks.com/story22000513/nanobodies-revive-tumor-suppressor-p53-a-new-hope-for-tumor-management